Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen Resistant Prostatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03016312
What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Hoffmann-La Roche 759
Not applicableEnded earlyNCT03440879
What this trial is testing

Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose

Who this might be right for
Prostate CancerResistance ExerciseAndrogen Deprivation Therapy
Norwegian School of Sport Sciences 23
Early research (Phase 1)Active Not RecruitingNCT06305598
What this trial is testing

Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Roswell Park Cancer Institute 3
Not applicableLooking for participantsNCT06449664
What this trial is testing

Training for Men Undergoing Androgen Deprivation Therapy.

Who this might be right for
Prostate Cancer
The Swedish School of Sport and Health Sciences 60
Testing effectiveness (Phase 2)Study completedNCT02987829
What this trial is testing

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Who this might be right for
Metastatic Castrate-resistant Prostate CancerAdenocarcinoma, Prostate
Tracon Pharmaceuticals Inc. 72
Large-scale testing (Phase 3)Looking for participantsNCT07311694
What this trial is testing

A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 370
Testing effectiveness (Phase 2)Study completedNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Not applicableStudy completedNCT01909440
What this trial is testing

Resistance Training and Protein Supplementation for Prostate Cancer Survivors

Who this might be right for
Prostate Cancer
University of Southern California 43
Testing effectiveness (Phase 2)WithdrawnNCT02065323
What this trial is testing

Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

Who this might be right for
Prostate Cancer
Oscar Goodman, Jr.
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Large-scale testing (Phase 3)Looking for participantsNCT06520345
What this trial is testing

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 520
Testing effectiveness (Phase 2)Ended earlyNCT01020305
What this trial is testing

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Sandy Srinivas 5
Very early researchLooking for participantsNCT05802121
What this trial is testing

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Who this might be right for
Prostate CancerMetabolic SyndromeObesity+4 more
Western University 30
Not applicableStudy completedNCT01383863
What this trial is testing

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Ipsen 180
Testing effectiveness (Phase 2)Study completedNCT05171387
What this trial is testing

Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Bayer 78
Testing effectiveness (Phase 2)Study completedNCT05848011
What this trial is testing

Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Androgen-Independent Prostatic CancerAndrogen-Independent Prostatic NeoplasmsProstate Cancer Recurrent+6 more
MacroGenics 154
Not applicableWithdrawnNCT01275651
What this trial is testing

Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)WithdrawnNCT05191017
What this trial is testing

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Prostate CancerProstatic CancerCancer of Prostate+5 more
Nuvation Bio Inc.
Not applicableStudy completedNCT01284608
What this trial is testing

Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)

Who this might be right for
Prostatic Cancer
AstraZeneca 197
Testing effectiveness (Phase 2)WithdrawnNCT04995978
What this trial is testing

Insulin Resistance and Androgen Deprivation Therapy

Who this might be right for
Prostate CancerInsulin Resistance
St. Louis University
Next Page